« SINTEF researchers devising energy-conserving aluminum parts manufacturing process | Main | UC Davis, Stanford team proposes reaction mechanism for key step in assembly of hydrogen-generating bacterial catalyst »
SRC launches Synthetic Biology Research on biomedical and minimal-power electronic devices for novel semiconductor applications
26 October 2013
Semiconductor Research Corporation (SRC), the world’s leading university-research consortium for semiconductor technologies, has launched the Semiconductor Synthetic Biology (SSB) research program on hybrid bio-semiconductor systems to provide insights and opportunities for future information and communication technologies. The program will initially fund research at six universities: MIT; the University of Massachusetts at Amherst; Yale; Georgia Tech; Brigham Young; and the University of Washington.
Funded by SRC’s Global Research Collaboration (GRC), SSB concentrates on synergies between synthetic biology and semiconductor technology that can foster exploratory, multi-disciplinary, longer-term university research leading to novel, breakthrough solutions for a wide range of industries. Results from the university research, guided by semiconductor industry needs, should significantly enhance and accelerate opportunities for advancing properties, design and applications for future generations of integrated circuits.
The first stage of the new program will support six exploratory projects in three related, but distinct, areas:
Cytomorphic-Semiconductor Circuit Design. Designers for semiconductor circuits and systems have begun to look to biological sciences for new approaches to analog and digital design and to circuits and system architectures, especially for minimum-energy electronic systems. The term cytomorphic electronics refers to electronic circuits and information processing inspired by the operation of chemical circuits and information processing in cells.
Bioelectric Sensors, Actuators and Energy Sources. Biological sensors have the potential to play an important role in multi-functional semiconductor systems. SRC plans to integrate live cells with CMOS technology and thus form a hybrid bio-semiconductor system that provides high signal sensitivity and specificity at low operating energy.
Molecular-precision Additive Fabrication. As the demands continue to grow for the most exacting pattern formation for semiconductor fabrication—and feature sizes shrink to the 5 nm regime—molecular-based self-assembly could offer an alternative to lithographically driven manufacturing. DNA can be used as an active agent to provide information content to guide structure formation. SRC plans to pursue processes that will both improve fabrication yields and provide purification of correctly formed structures to significantly reduce the occurrence of defects in making DNA nanostructures.
Results from this Stage 1 research program will be used to guide future generations of SSB research. Approximately $2.25M will be invested by SRC-GRC for Phase 1 research.
TrackBack URL for this entry:
Listed below are links to weblogs that reference SRC launches Synthetic Biology Research on biomedical and minimal-power electronic devices for novel semiconductor applications: